Literature DB >> 16356313

The Arizona Telemedicine Program business model.

Gail P Barker1, Elizabeth A Krupinski, Richard A McNeely, Michael J Holcomb, Ana Maria Lopez, Ronald S Weinstein.   

Abstract

The Arizona Telemedicine Program (ATP) was established in 1996 when state funding was provided to implement eight telemedicine sites. Since then the ATP has expanded to connect 55 health-care organizations through a membership programme formalized through legal contracts. The ATP's membership model is based on an application service provider (ASP) concept, whereby organizations can share services at lower cost; that is, the ATP acts as a broker for services. The membership fee schedule is flexible, allowing clients to purchase only those services desired. An annual membership fee is paid by every user, based on the services requested. The membership programme income has provided a steady revenue stream for the ATP. The membership-derived revenue represented 30% of the ATP's 2.6 million dollars total income during fiscal year 2003/04.

Entities:  

Mesh:

Year:  2005        PMID: 16356313     DOI: 10.1177/1357633X0501100804

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  3 in total

Review 1.  Stroke telemedicine.

Authors:  Bart M Demaerschalk; Madeline L Miley; Terri-Ellen J Kiernan; Bentley J Bobrow; Doren A Corday; Kay E Wellik; Maria I Aguilar; Timothy J Ingall; David W Dodick; Karina Brazdys; Tiffany C Koch; Michael P Ward; Phillip C Richemont
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

2.  Key components and critical factors for developing a telehealth business framework: a qualitative study.

Authors:  Farnia Velayati; Haleh Ayatollahi; Morteza Hemmat; Reza Dehghan
Journal:  BMC Med Inform Decis Mak       Date:  2021-12-04       Impact factor: 2.796

Review 3.  Telehealth Business Models and Their Components: Systematic Review.

Authors:  Farnia Velayati; Haleh Ayatollahi; Morteza Hemmat; Reza Dehghan
Journal:  J Med Internet Res       Date:  2022-03-29       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.